Status:
UNKNOWN
XIST Gene Deletion in Breast Cancer Therapy
Lead Sponsor:
Assiut University
Conditions:
Breast Cancer
Eligibility:
FEMALE
20+ years
Brief Summary
Very little is known about the role of X-inactive specific transcript RNA in human breast cancer and in regulating different response to therapy . the relation between the breast cancer predisposing ...
Detailed Description
breast cancer is an important cause of morbidity and mortality in women .Genetics of female contributes to her risk of having breast cancer . this disease is still discovered in their late stages due ...
Eligibility Criteria
Inclusion
- Newly diagnosed patients of breast cancer admitted to south egypt cancer institute at different stages of the disease
Exclusion
- Other malignant diseases. Male breast cancer . Female with other sex linked diseases . Patients received chemotherapy for breast cancer .
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2022
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT04093609
Start Date
March 1 2020
End Date
March 1 2022
Last Update
September 18 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.